Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of CJC-1134-PC added to metformin in patients with type 2 diabetes; the study is completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CJC-1134-PC

Snippet

Sponsor: ConjuChem | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2017-06-02